Beyond Leaf & Root
July 2026
Beyond the root vs leaf debate lies a deeper question: how should Ashwagandha be evaluated? This whitepaper examines standardized ashwagandha root and leaf extract through the lens of safety, characterization, and clinical relevance. Download now to explore the science driving responsible botanical innovation.
This Technical Paper is brought to you by Arjuna Natural Pvt. Ltd.
READ THIS NEXT: Beauty-from-Within: To Shine on the Outside
Supplements
Kaneka pitches “mitoceuticals” as mechanism-led mitochondrial health supplements
Cellular health is becoming increasingly important as industry and science reveal that health systems are interconnected. The mitochondria are especially central in this understanding, as it addresses healthy aging, healthspan,...
Supplements
David Beckham’s IM8 longevity supplement brand secures US$1B in funding
Prenetics Global, parent of David Beckham’s co-founded longevity supplement IM8, has closed US$1 billion in growth financing from General Catalyst’s Customer Value Fund (CVF). Since the label’s NASA...
Supplements
NPA and CRN reject ACP call for US supplement regulatory overhaul and premarket approval
The Natural Products Association (NPA) and Council for Responsible Nutrition (CRN) counter recent recommendations to modernize the US supplement legislation framework, such as premarket authorization or regulating these products...
